Abstract
Objective: This research attempted to clarify impact of dietary intervention on nutritional status, immune indicators including IgM, IgA, and IgG levels, and quality of life of patients with gastrointestinal tumors during chemotherapy.
Methods: The 100 patients with gastrointestinal tumors undergoing chemotherapy in our hospital from January 2023 to June 2024 received selection and division into a control group (CG) and a study group (SG) according to different nursing methods, with 50 cases each. The CG received conventional chemotherapy nursing intervention, and SG received dietary nursing on the basis of conventional nursing in CG. The nutritional indicators including body mass index (BMI), oral mucosal cell apoptosis rate, hemoglobin (HGB), and serum albumin (ALB) levels, immune indicators including IgM, IgA, and IgG levels and quality of life before and after nursing between both groups received comparison.
Results: After nursing, BMI, oral mucosa cell apoptosis rate, HGB level, and serum ALB level in both groups exhibited elevation relative to those before nursing, and SG exhibited elevation relative to CG (P < 0.05); IgM, IgA, and IgG levels in both groups exhibited elevation relative to those before nursing, and SG exhibited elevation relative to CG (P < 0.05); physical functioning scores, social functioning scores, psychological functioning scores, and material life scores in both groups exhibited elevation relative to those before nursing, and SG exhibited elevation relative to CG (P < 0.05).
Conclusion: Providing dietary nursing intervention for patients with gastrointestinal tumors during chemotherapy can effectively facilitate their nutritional status, enhance immune function, and improve their quality of life.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.